These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1778869)

  • 1. Role of the quinolones in the treatment of legionellosis.
    Meyer RD
    J Antimicrob Chemother; 1991 Nov; 28(5):623-5. PubMed ID: 1778869
    [No Abstract]   [Full Text] [Related]  

  • 2. In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella spp.
    Croco MA; Biedenbach DJ; Pfaller MA; Doern GV; Jones RN
    J Antimicrob Chemother; 1998 Nov; 42(5):672-3. PubMed ID: 9848457
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pneumonia due to Legionella. Macrolides or quinolones?].
    Gómez J; Ruiz Gómez J; Sabrià M
    Rev Esp Quimioter; 2002 Mar; 15(1):21-4. PubMed ID: 12582433
    [No Abstract]   [Full Text] [Related]  

  • 4. [Are quinolones the drugs of choice in pneumonia caused by microorganisms of Legionella genus?].
    Bouza Santiago E; Rodríguez-Créixems M
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 1():19-23. PubMed ID: 10563106
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of fluoroquinolones for intracellular pathogens.
    Pocidalo JJ
    Rev Infect Dis; 1989; 11 Suppl 5():S979-84. PubMed ID: 2672263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nosocomial legionellosis: prevention and management.
    Levin AS
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):57-68. PubMed ID: 19622057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Legionellosis (Legionnaires' disease, Pontiac fever)].
    Tateyama M; Saito A
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):11-4. PubMed ID: 10088325
    [No Abstract]   [Full Text] [Related]  

  • 8. [Difluoroquinolone lomefloxacin (Maxaquin): its role among fluoroquinolones, possibilities and prospectives].
    Padeĭskaia EN
    Antibiot Khimioter; 1998; 43(10):4-9. PubMed ID: 9825101
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.
    Stout JE; Sens K; Mietzner S; Obman A; Yu VL
    Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and control of legionellosis, singapore.
    Lam MC; Ang LW; Tan AL; James L; Goh KT
    Emerg Infect Dis; 2011 Jul; 17(7):1209-15. PubMed ID: 21762574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Legionella jordanis pneumonia unresponsive to fluoroquinolones in a non-immunocompromised host.
    Baty V; Hoen B; Schuhmacher H; Amiel C; Reyrolle M; Garin H; Canton P
    Scand J Infect Dis; 1997; 29(3):319-20. PubMed ID: 9255901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study of 30 cases of Legionella pneumonia in the Kansai region.
    Maniwa K; Taguchi Y; Ito Y; Mishima M; Yoshida S
    J Infect Chemother; 2006 Oct; 12(5):272-6. PubMed ID: 17109091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Fragrance Ingredients on the Uptake of Legionella pneumophila into Acanthamoeba castellanii.
    Nomura H; Takahashi S; Tohara Y; Isshiki Y; Sakuda K; Sakuma K; Kondo S
    Biocontrol Sci; 2018; 23(4):241-244. PubMed ID: 30584212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two linked cases of legionellosis with an unusual industrial source.
    O'Keefe NS; Heinrich-Morrison KA; McLaren B
    Med J Aust; 2005 Nov; 183(9):491-2. PubMed ID: 16274354
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro and in vivo activities of sparfloxacin in Legionella infections.
    Saito A; Gaja M
    Drugs; 1995; 49 Suppl 2():250-2. PubMed ID: 8549320
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis.
    Furneri PM; Bazzano M; Campo L; Cesana M; Tempera G
    Chemotherapy; 1994; 40(2):104-8. PubMed ID: 8131632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infections due to Legionella non-pneumophila].
    Rossi G
    Recenti Prog Med; 2004 Jun; 95(6):316-8; quiz 344. PubMed ID: 15248416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophila.
    Edelstein PH; Hu B; Edelstein MA
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2533-5. PubMed ID: 15917565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legionella: macrolides or quinolones?
    Pedro-Botet L; Yu VL
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():25-30. PubMed ID: 16669926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Legionella strains in cooling towers and legionellosis cases in New Zealand.
    Lau R; Maqsood S; Harte D; Caughley B; Deacon R
    J Environ Health; 2013; 75(6):82-9. PubMed ID: 23397654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.